Clinical trial · Observational
Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms
NCT07337967CI-TRIAL-00100777not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Reticulocyte parameters as early indicators of bone marrow erythropoietic activity in chronic B lymphoproliferative neoplasms
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| B Chronic Lymphocytic Leukemia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Reticulocyte count
- timeFrame
- 1 year
- description
- Absolute peripheral blood reticulocyte count measured in patients with chronic B-cell lymphoproliferative disorders (CLPDs). Unit of Measure: ×10⁹/L
- measure
- Reticulocyte percentage
- timeFrame
- 1 year
- description
- Percentage of reticulocytes among total red blood cells in peripheral blood of patients with CLPDs. Unit of Measure: %
- measure
- Immature reticulocyte fraction (IRF)
- timeFrame
- 1 year
- description
- Proportion of immature reticulocytes in peripheral blood measured in patients with CLPDs. Unit of Measure: %
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: \- Newly diagnosed adult patients with Chronic B LymphoPoliferative neoplasm according to WHO classification. Exclusion Criteria: 1\) Patients received chemotherapy. 1. Patients with Active bleeding 2. Patients with recent blood transfusion (less than 2 weeks). 3. Patients on haematinics or vitamin B 12 therapy
References
Publications (0)
Data not yet available
No reference posted for this study.